Gene · 53335
Papers3,029
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,021 to 1,040 of 3,029
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Effective tools for RNA-derived therapeutics: siRNA interference or miRNA mimicry. | Theranostics | 2021 | 34522211 | PubTator, text mining | PubMed |
| Atypical genomic cortical patterning in autism with poor early language outcome. | Sci Adv | 2021 | 34516910 | PubTator, text mining | PubMed |
| Circular RNA: A potential diagnostic, prognostic, and therapeutic biomarker for human triple-negative breast cancer. | Mol Ther Nucleic Acids | 2021 | 34513294 | PubTator, text mining | PubMed |
| Gene signatures associated with barrier dysfunction and infection in oral lichen planus identified by analysis of transcriptomic data. | PLoS One | 2021 | 34506598 | PubTator, text mining | PubMed |
| SPaRTAN, a computational framework for linking cell-surface receptors to transcriptional regulators. | Nucleic Acids Res | 2021 | 34500467 | PubTator, text mining | PubMed |
| Single-nuclei transcriptomes from human adrenal gland reveal distinct cellular identities of low and high-risk neuroblastoma tumors. | Nat Commun | 2021 | 34493726 | PubTator, text mining | PubMed |
| Genomics and metabolomics of early-stage thioacetamide-induced liver injury: An interspecies study between guinea pig and rat. | Toxicol Appl Pharmacol | 2021 | 34492290 | PubTator, text mining | PubMed |
| Strategies to improve pharmacogenomic-guided treatment options for patients with β-hemoglobinopathies. | Expert Rev Hematol | 2021 | 34490838 | PubTator, text mining | PubMed |
| A novel break site of EML4-ALK report and a rare PRKAR1A-ALK report analyzed by different ALK detection platforms in non-small cell lung cancer patients. | Thorac Cancer | 2021 | 34490727 | PubTator, text mining | PubMed |
| Reproducible immortalization of erythroblasts from multiple stem cell sources provides approach for sustainable RBC therapeutics. | Mol Ther Methods Clin Dev | 2021 | 34485592 | PubTator, text mining | PubMed |
| Case Report: Identification of Two Rare Fusions, PDK1-ALK and STRN-ALK, That Coexist in a Lung Adenocarcinoma Patient and the Response to Alectinib. | Front Oncol | 2021 | 34485156 | PubTator, text mining | PubMed |
| Forward and Reverse Genetics of B Cell Malignancies: From Insertional Mutagenesis to CRISPR-Cas. | Front Immunol | 2021 | 34484175 | PubTator, text mining | PubMed |
| Functional characterization of T2D-associated SNP effects on baseline and ER stress-responsive β cell transcriptional activation. | Nat Commun | 2021 | 34475398 | PubTator, text mining | PubMed |
| Epigenetic programming underpins B-cell dysfunction in peanut and multi-food allergy. | Clin Transl Immunology | 2021 | 34466226 | PubTator, text mining | PubMed |
| Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2021: Looking Forward as the Network Celebrates its 20th Year. | Transplant Cell Ther | 2021 | 34461278 | PubTator, text mining | PubMed |
| Designing Lentiviral Vectors for Gene Therapy of Genetic Diseases. | Viruses | 2021 | 34452394 | PubTator, text mining | PubMed |
| Non-Coding Variants in Cancer: Mechanistic Insights and Clinical Potential for Personalized Medicine. | Noncoding RNA | 2021 | 34449663 | PubTator, text mining | PubMed |
| Erythropoietin (EPO) as a Key Regulator of Erythropoiesis, Bone Remodeling and Endothelial Transdifferentiation of Multipotent Mesenchymal Stem Cells (MSCs): Implications in Regenerative Medicine. | Cells | 2021 | 34440909 | PubTator, text mining | PubMed |
| Familiarity Breeds Strategy: In Silico Untangling of the Molecular Complexity on Course of Autoimmune Liver Disease-to-Hepatocellular Carcinoma Transition Predicts Novel Transcriptional Signatures. | Cells | 2021 | 34440687 | PubTator, text mining | PubMed |
| Genetic Alterations in Childhood Acute Lymphoblastic Leukemia: Interactions with Clinical Features and Treatment Response. | Cancers (Basel) | 2021 | 34439222 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/53335/papers?page=52